ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 618770 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 618770; 2) Community: the network communities that were significantly associated with the response to NSC 618770; 3) Molecule: the relationships between components within communities and NSC 618770; 4) MDR: the compounds that were significantly associated with the NSC 618770.

NSC Compound Enrichment Correlation
NSC 79563 1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine 0.0208632511155816 0.23528221
NSC 136468 Null 0.0208632511155817 0.53542906
NSC 22348 1H-Naphth[2,3-d]imidazole-4,9-dione, 1-(p-bromophenyl)- 2-methyl- 0.0208632511155817 0.50935912
NSC 237020 TA 1067 0.0208632511155817 0.48028582
NSC 254677 Phomazarin 0.0208632511155817 -0.30582625
NSC 26074 Null 0.0208632511155817 0.38644104
NSC 335766 Quinazoline, 4-ethyl-6-methoxy-7-(oxiranylmethoxy)- 0.0208632511155817 0.6422369
NSC 43675 General Chemicals 8993 0.0208632511155817 0.47731452
NSC 625350 Benzenepropanoic acid, .beta.-(benzoylamino)-.alpha.- hydroxy-, (9,10-dihydro-9,10-dioxo-2-anthracenyl)methyl ester (R*,R*) 0.0210461623330205 -0.43370718
NSC 752879 3-(3-chloro-5-methoxyphenyl)-N-(2-(4-methylpiperazin-1-yl)ethyl)-4-(pyridin-4-yl)-1H-pyrazole-1-carboxamide 0.0210461623330205 -0.36700503
Total:163  Current:98    [First] [Prev] [Next] [Last]